Financials
- Market Capitalization 55.3 M
- Employee 21
- Founded 2015
- CEO N/A
- Website www.inmunebio.com
- Headquarter Nevada, United States
- FIGI BBG00LW94L98
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.69
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4250 | BOLD Boundless Bio, Inc. - Common Stock | 2.45 USD | -0.41% | -1.21% | +71.33% | +111.21% | 55.04 M USD | ||
| 4253 | BYSI BeyondSpring, Inc. - Ordinary Shares | 1.43 USD | +7.52% | -12.80% | -11.18% | -37.00% | 58.80 M USD | ||
| 4266 | TIL Instil Bio, Inc. - Common Stock | 7.66 USD | -2.05% | -1.42% | -2.67% | -60.70% | 51.95 M USD | ||
| 4272 | XLO Xilio Therapeutics, Inc. - Common Stock | 9.01 USD | -0.22% | -3.94% | +6.00% | +1134.25% | 52.10 M USD |